Atlas Trials

Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas

Clinical trial NCT01263418 · WITHDRAWN

Trial details

NCT number
NCT01263418
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, B-Cell, Marginal ZoneLymphoma, Low-GradeLymphoma, Intermediate-Grade
Start date
2011-06-01
Primary completion
2016-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.